Antenatal magnesium sulfate treatment for women at risk of preterm birth is safe and might decrease the risk of cerebral palsy
- PMID: 29921710
- DOI: 10.1136/bmjebm-2018-110897
Antenatal magnesium sulfate treatment for women at risk of preterm birth is safe and might decrease the risk of cerebral palsy
Conflict of interest statement
Competing interests: Both authors are primary investigators on an ongoing randomised controlled trial on the use of magnesium sulfate in preterm birth.
Comment on
-
Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.PLoS Med. 2017 Oct 4;14(10):e1002398. doi: 10.1371/journal.pmed.1002398. eCollection 2017 Oct. PLoS Med. 2017. PMID: 28976987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources